BLADDER TRANSITIONAL CELL CARCINOMA STAGE II

This adverse event was reported 46 times

These drugs are most commonly taken by patients reporting BLADDER TRANSITIONAL CELL CARCINOMA STAGE II:

# Drug Count
0 ADALIMUMAB 15
1 PIOGLITAZONE 14
2 ETANERCEPT 9
3 ASPIRIN 8
4 ASPIRIN 325 MG 8
5 ASPIRIN 81 MG 8
6 GOLIMUMAB 7
7 INFLIXIMAB 7
8 METHOTREXATE SODIUM 7
9 SITAGLIPTIN 7
See all common drugs associated with BLADDER TRANSITIONAL CELL CARCINOMA STAGE II

BLADDER TRANSITIONAL CELL CARCINOMA STAGE II is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Lipid Emulsion [EPC] 1 0.0004
1 GLP-2 Analog [EPC] 1 0.0001
2 Peroxisome Proliferator Receptor alpha Agonist [EPC] 4 0.0001
3 Interleukin-17A Antagonist [EPC] 2 0.0001
4 Antimycobacterial [EPC] 1 0.0000
5 Xanthine Oxidase Inhibitor [EPC] 6 0.0000
6 Sulfonylurea [EPC] 3 0.0000
7 Nitrate Vasodilator [EPC] 2 0.0000
8 Calcium [EPC] 3 0.0000
9 Antirheumatic Agent [EPC] 2 0.0000
See all drug classes enriched for association with BLADDER TRANSITIONAL CELL CARCINOMA STAGE II